US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 167 actively recruiting studies with Wisconsin sites out of 167 registered in total. The busiest research areas in Wisconsin are Breast Cancer, Prostate Cancer, Colorectal Cancer. Leading sponsors running trials in the state include University of Wisconsin, Madison, Medical College of Wisconsin, National Cancer Institute (NCI). By stage, Wisconsin trials break down as Phase 1 (34), Phase 2 (47), Phase 3 (43), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
167
Recruiting Now
167
← Back to US Map
Top Conditions in Wisconsin
Breast Cancer (5)Prostate Cancer (4)Colorectal Cancer (3)Solid Tumor (3)Acute Myeloid Leukemia (3)Anxiety (3)Heart Failure (3)Mantle Cell Lymphoma (MCL) (3)Healthy (2)Metastatic Castration-resistant Prostate Cancer (2)Pancreatic Ductal Adenocarcinoma (2)Relapsing Remitting Multiple Sclerosis (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 167 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 167. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT07718113 N/A
Recruiting
Exercise Snacking and Cardiometabolic Health
Condition
Physical Inactivity
Enrollment
60 pts
Location
United States
Sponsor
University of Wisconsin, River
View Trial →
NCT06859762 Phase 1
Recruiting
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
630 pts
Location
United States, China
Sponsor
MediLink Therapeutics (Suzhou)
View Trial →
NCT06424288 Phase 3
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps Peop...
Condition
Heart Failure
Enrollment
6,712 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT06780670 Phase 2, Phase 3
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Pr...
Condition
Prostate Cancer
Enrollment
443 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06834373 Phase 2
Recruiting
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggress...
Condition
Large B-Cell Lymphoma With IRF4 Rearrangement
Enrollment
41 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07361510 Phase 3
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participan...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07103018 Phase 1
Recruiting
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Pr...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
144 pts
Location
United States
Sponsor
K36 Therapeutics, Inc.
View Trial →
NCT06796504 N/A
Recruiting
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multi...
Condition
Relapsing Remitting Multiple Sclerosis
Enrollment
60 pts
Location
United States
Sponsor
SetPoint Medical Corporation
View Trial →
NCT05592626 Phase 1, Phase 2
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fu...
Condition
Advanced Solid Tumors
Enrollment
366 pts
Location
United States, Canada, France
Sponsor
Marengo Therapeutics, Inc.
View Trial →
NCT07159126 Phase 1
Recruiting
A Study of DS3610a in Participants With Advanced Solid Tumor
Condition
Solid Tumors
Enrollment
70 pts
Location
United States, France, Japan
Sponsor
Daiichi Sankyo
View Trial →
NCT06743126 Phase 3
Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously T...
Condition
Melanoma, Cutaneous Malignant
Enrollment
450 pts
Location
United States, Canada, France
Sponsor
Immatics US, Inc.
View Trial →
NCT06763952 N/A
Recruiting
Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes
Condition
Diabetic Retinopathy
Enrollment
6,900 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06908538 N/A
Recruiting
Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Li...
Condition
Amputation
Enrollment
2,000 pts
Location
United States
Sponsor
AtriCure, Inc.
View Trial →
NCT04896606 Phase 1, Phase 2
Recruiting
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease
Condition
Covid19
Enrollment
50 pts
Location
United States
Sponsor
New York Medical College
View Trial →
NCT00736749 N/A
Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Gro...
Condition
Hematopoietic Cell Transplantation Recipient
Enrollment
25,000 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT06556654 N/A
Recruiting
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (RE...
Condition
Breast Reconstruction Surgery
Enrollment
180 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
NCT07492680 Phase 2
Recruiting
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other ...
Condition
Solid Tumors
Enrollment
254 pts
Location
United States, Belgium, Canada
Sponsor
Bristol-Myers Squibb
View Trial →
NCT05006482 Phase 3
Recruiting
Geriatric Evaluation and Management With Survivorship Health Education for Older...
Condition
Lymphoma
Enrollment
668 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT03072927 N/A
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Condition
Lumbar Spinal Stenosis
Enrollment
8,000 pts
Location
United States
Sponsor
Stryker Instruments
View Trial →
NCT03151629 N/A
Recruiting
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Condition
Prostate Cancer
Enrollment
5,000 pts
Location
United States, Australia, Barbados
Sponsor
Prostate Cancer Clinical Trial
View Trial →
NCT06710756 Phase 1, Phase 2
Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
112 pts
Location
United States
Sponsor
Perspective Therapeutics
View Trial →
NCT07218237 N/A
Recruiting
Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnan...
Condition
Preeclampsia
Enrollment
90 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT07144163 Phase 3
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
Condition
Congenital Adrenal Hyperplasia
Enrollment
150 pts
Location
United States, Argentina, Australia
Sponsor
Crinetics Pharmaceuticals Inc.
View Trial →
NCT04088071 N/A
Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Condition
Paroxysmal Atrial Fibrillation
Enrollment
20,000 pts
Location
United States, Canada
Sponsor
Heart Rhythm Clinical and Rese
View Trial →
NCT06760819 Phase 2
Recruiting
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) T...
Condition
Advanced Solid Tumors
Enrollment
111 pts
Location
United States, Australia, Canada
Sponsor
Bayer
View Trial →
Page 6 of 7 — 167 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology